SHEILA TURNER: Open Payments
NPI 1639317787 · HAMDEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$784 in 35 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $149 · 2025 $784
Food & beverage: $784
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $151 |
| Astellas Pharma US Inc | 4 | $106 |
| ABBVIE INC. | 4 | $79 |
| PFIZER INC. | 3 | $63 |
| Novo Nordisk Inc | 2 | $57 |
| Otsuka America Pharmaceutical, Inc. | 3 | $48 |
| Lilly USA, LLC | 2 | $48 |
| Ardelyx, Inc. | 2 | $48 |
| Lundbeck LLC | 2 | $45 |
| GlaxoSmithKline, LLC. | 2 | $38 |
Products named: Veozah, REXULTI, VRAYLAR, AIRSUPRA, BREZTRI, PAXLOVID, IBSRELA, INSPIRE.
Industry payments across CT — which companies pay providers there.
